東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Overcoming breast cancer therapy resistance = from mechanisms to precision and AI-powered approaches /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Overcoming breast cancer therapy resistance/ edited by Zodwa Dlamini.
其他題名:	from mechanisms to precision and AI-powered approaches /
其他作者:	Dlamini, Zodwa.
出版者:	Cham :Springer Nature Switzerland : : 2024.,
面頁冊數:	ix, 394 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Breast - Cancer -
電子資源:	https://doi.org/10.1007/978-3-031-52860-6
ISBN:	9783031528606

Overcoming breast cancer therapy resistance = from mechanisms to precision and AI-powered approaches /
Overcoming breast cancer therapy resistancefrom mechanisms to precision and AI-powered approaches /[electronic resource] :edited by Zodwa Dlamini. - Cham :Springer Nature Switzerland :2024. - ix, 394 p. :ill., digital ;24 cm.

This book addresses the pressing problem of drug resistance in the treatment of breast cancer. It provides a comprehensive understanding of the complex mechanisms underlying drug resistance and presents the latest advances in therapeutic approaches to overcome this enormous challenge. The book begins with an introduction to the biology of breast cancer, treatment modalities and the mechanisms of drug resistance. This includes the principles of drug resistance in targeted, immune-, endocrine and chemotherapy. In the following sections, the authors present innovative strategies to overcome drug resistance and new research directions, among others the role of the microbiome in drug resistance, molecular profiling of patients for personalized medical care, and new drug delivery systems. Finally, the book concludes with a discussion of the differences in the prevalence and treatment success of breast cancer between high- and low-income countries. This book is an informative resource for students, researchers, and clinicians in the field of breast cancer research and oncology in general.

ISBN: 9783031528606

Standard No.: 10.1007/978-3-031-52860-6doiSubjects--Topical Terms:

900056
Breast
--Cancer

LC Class. No.: RC280.B8

Dewey Class. No.: 616.99449061

Overcoming breast cancer therapy resistance = from mechanisms to precision and AI-powered approaches /
LDR:02115nmm a2200313 a 4500 001 2371113
003 DE-He213
005 20240604104004.0
006 m d
007 cr nn 008maaau
008 241127s2024 sz s 0 eng d
020 $a 9783031528606 $q (electronic bk.)
020 $a 9783031528590 $q (paper)
024 7 $a 10.1007/978-3-031-52860-6 $2 doi
035 $a 978-3-031-52860-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99449061 $2 23
090 $a RC280.B8 $b O96 2024
245 0 0 $a Overcoming breast cancer therapy resistance $h [electronic resource] : $b from mechanisms to precision and AI-powered approaches / $c edited by Zodwa Dlamini.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a ix, 394 p. : $b ill., digital ; $c 24 cm.
520 $a This book addresses the pressing problem of drug resistance in the treatment of breast cancer. It provides a comprehensive understanding of the complex mechanisms underlying drug resistance and presents the latest advances in therapeutic approaches to overcome this enormous challenge. The book begins with an introduction to the biology of breast cancer, treatment modalities and the mechanisms of drug resistance. This includes the principles of drug resistance in targeted, immune-, endocrine and chemotherapy. In the following sections, the authors present innovative strategies to overcome drug resistance and new research directions, among others the role of the microbiome in drug resistance, molecular profiling of patients for personalized medical care, and new drug delivery systems. Finally, the book concludes with a discussion of the differences in the prevalence and treatment success of breast cancer between high- and low-income countries. This book is an informative resource for students, researchers, and clinicians in the field of breast cancer research and oncology in general.
650 0 $a Breast $x Cancer $x Chemotherapy. $3 900056
650 0 $a Drug resistance in cancer cells. $3 658434
650 1 4 $a Cancer Therapy. $3 3594090
650 2 4 $a Cancer Nanotechnology. $3 3531318
650 2 4 $a Oncology. $3 751006
700 1 $a Dlamini, Zodwa. $3 3627663
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-52860-6
950 $a Biomedical and Life Sciences (SpringerNature-11642)